HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 56 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $1,336,000 | -34.9% | 804,964 | -2.0% | 0.07% | -40.0% |
Q1 2019 | $2,053,000 | -12.6% | 821,116 | -11.2% | 0.11% | -33.7% |
Q4 2018 | $2,348,000 | -50.6% | 924,300 | -1.8% | 0.17% | -35.7% |
Q3 2018 | $4,753,000 | +59.3% | 941,170 | +2.8% | 0.26% | +43.3% |
Q2 2018 | $2,984,000 | +2.7% | 915,449 | +14.1% | 0.18% | -14.3% |
Q1 2018 | $2,905,000 | +199.8% | 802,521 | +68.1% | 0.21% | +176.3% |
Q4 2017 | $969,000 | +36.9% | 477,438 | +14.6% | 0.08% | +28.8% |
Q3 2017 | $708,000 | +276.6% | 416,608 | +488.3% | 0.06% | +247.1% |
Q2 2017 | $188,000 | -17.5% | 70,810 | +114.5% | 0.02% | -26.1% |
Q1 2017 | $228,000 | – | 33,010 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 5,790,269 | $3,848,000 | 3.74% |
PERKINS CAPITAL MANAGEMENT INC | 2,353,153 | $1,564,000 | 1.35% |
Diametric Capital, LP | 269,822 | $179,000 | 0.15% |
Nantahala Capital Management | 5,000,000 | $3,323,000 | 0.12% |
Sio Capital Management, LLC | 300,000 | $199,000 | 0.06% |
Cowen Prime Services LLC | 100,000 | $66,000 | 0.03% |
Fondren Management LP | 40,375 | $27,000 | 0.02% |
Kalos Management, Inc. | 66,900 | $46,000 | 0.02% |
Alyeska Investment Group, L.P. | 1,387,665 | $922,000 | 0.01% |
Hayden Royal, LLC | 12,000 | $8,000 | 0.01% |